Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)

CM Driessen; JC Ham; M te Loo; Esther van Meerten; M van Lamoen; MH Hakobjan; RP Takes; WT van der Graaf; JH Kaanders; MJH Coenen; CM van Herpen

doi:10.3390/cancers11040551

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)

CM Driessen, JC Ham, M te Loo, Esther van Meerten, M van Lamoen, MH Hakobjan, RP Takes, WT van der Graaf, JH Kaanders, MJH Coenen, CM van Herpen

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

19 Downloads (Pure)

Original language	Undefined/Unknown
Article number	551
Journal	Cancers
Volume	11
Issue number	4
DOIs	https://doi.org/10.3390/cancers11040551
Publication status	Published - 2019

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers11040551

Repub_117032_O-A.pdfFinal published version, 602 KB

http://hdl.handle.net/1765/117032

Cite this

Driessen, CM., Ham, JC., te Loo, M., van Meerten, E., van Lamoen, M., Hakobjan, MH., Takes, RP., van der Graaf, WT., Kaanders, JH., Coenen, MJH., & van Herpen, CM. (2019). Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). Cancers, 11(4), Article 551. https://doi.org/10.3390/cancers11040551

@article{18c34a4edccd4fe2b6bb9d469167848a,

title = "Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)",

author = "CM Driessen and JC Ham and {te Loo}, M and {van Meerten}, Esther and {van Lamoen}, M and MH Hakobjan and RP Takes and {van der Graaf}, WT and JH Kaanders and MJH Coenen and {van Herpen}, CM",

year = "2019",

doi = "10.3390/cancers11040551",

language = "Undefined/Unknown",

volume = "11",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "4",

}

Driessen, CM, Ham, JC, te Loo, M, van Meerten, E, van Lamoen, M, Hakobjan, MH, Takes, RP, van der Graaf, WT, Kaanders, JH, Coenen, MJH & van Herpen, CM 2019, 'Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)', Cancers, vol. 11, no. 4, 551. https://doi.org/10.3390/cancers11040551

TY - JOUR

T1 - Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)

AU - Driessen, CM

AU - Ham, JC

AU - te Loo, M

AU - van Meerten, Esther

AU - van Lamoen, M

AU - Hakobjan, MH

AU - Takes, RP

AU - van der Graaf, WT

AU - Kaanders, JH

AU - Coenen, MJH

AU - van Herpen, CM

PY - 2019

Y1 - 2019

U2 - 10.3390/cancers11040551

DO - 10.3390/cancers11040551

M3 - Article

C2 - 30999660

SN - 2072-6694

VL - 11

JO - Cancers

JF - Cancers

IS - 4

M1 - 551

ER -